期刊
PHARMACOLOGY
卷 92, 期 1-2, 页码 84-89出版社
KARGER
DOI: 10.1159/000351971
关键词
Dopamine receptors; Antagonist binding; G-protein-coupled inwardly rectifying potassium; Patch clamp
资金
- NIH/NIMH [R-21 NS050658]
- NIH/NIDA [R-01 DA13584]
SV 293 [1-([5-methoxy-1H-indol-3-yl]methyl)-4-(4-[methylthio] phenyl)piperidin-4-ol] binds with 100-fold higher affinity to human D2 receptors compared to the human D3 and D4 dopamine receptor subtypes. We investigated the intrinsic efficacy of this compound at the D2 dopamine receptor subtype using both: (1) a forskolin-dependent adenylyl cyclase inhibition assay and (2) an electrophysiological assay for evaluating coupling to G-protein-coupled inwardly rectifying potassium channels. In both assays SV 293 was found to be a neutral antagonist capable of blocking the effects of the full D2-like receptor agonist quinpirole. Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated. Copyright (C) 2013 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据